TEM-28 from an Escherichia coli clinical isolate is a member of the his-164 family of TEM-1 extended-spectrum β-lactamases

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 260-262

  Bradford, Patricia A ^a   Jacobus, Nilda V ^a   Bhachech, Niraja ^a   Bush, Karen ^a  

^a WYETH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; ESCHERICHIA COLI; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

BETA-LACTAMASES; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ISOELECTRIC FOCUSING; PLASMIDS; TRANSFORMATION, GENETIC;

EID: 0030048719     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.260     Document Type: Article

References (22)

1. Bauernfeind, A., and G. Hörl. 1987. Novel R-factor borne β-lactamase of Escherichia coli conferring resistance to cephalosporins Infection 15:257-259.
2. Bradford, P. A., C. E. Cherubin, V. Idemyor, B. A. Rasmussen, and K. Bush. 1994. Multiply resistant Klebstella pneumomae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidimc-hydrolyzing β-lactamases in a single isolate. Antimicrob. Agents Chemother. 38:761-766.
3. Bradford, P. A., C. Urban, A. Jaiswal, N. Mariano, B. A. Rasmussen, S. J. Projan, J. J. Rahal, and K. Bush. 1995. SHV-7, novel cefotaxime-hydrolyzing β-lactamase. identified in Eschericlua coli isolates from hospitalized nursing home patients. Antimicrob. Agents Chemother. 39:899-905.
4. Bush, K., C. Macalintal, B. A. Rasmussen, V. J. Lee, and Y. Yang. 1993. Kinetic interactions of tazobactam with β-Iactamases from all major structural classes Antimicrob. Agents Chemother. 37:851-858.
5. Bush, K., and S. B. Singer. 1989. Effective cooling allows sonication to be used for liberation of β-lactamases from gram-negative bacteria. J. Antimicrob. Chemother. 24:82-84.
6. Goussard, S., W. Sougakoff, C. Mabilat, A, Bauernfeind, and P. Courvalin. 1991. An ISl-like element is responsible for high-level synthesis of extended-spectrum β-lactamase TEM-6 in Enterobacteriaceae. J. Gen. Microbiol 137: 2681-2687.
7. Jacoby, G. A., and A. A. Medeiros. 1991. More extended-spectrum β-lactamases Antimicrob. Agents Chemother 35:1697-1704
8. Mabilat, C., and P. Courvalin. 1990. Development of "oligotyping" for characterization and molecular epidemiology of TEM β-lactamases in members of the family Enterbacteriaceae. Antimicrob Agents Chemother. 34: 2210-2216.
9. Matthew, M. A., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of isoelectric focusing for detection and identification of heta-lactamases. J. Gen. Microbiol 88:169-178.
10. Meyer, K. S., C. Urban, J. A. Eagan, B. J. Berger, and J. J. Kahal. 1993. Nosocomial outbreak of Klebsiella infection resistant to late generation cephalosporins. Ann. Intern. Med 119:353-358
11. Morosini, M. I., R. Canton, J. Martinez-Beltran, M. C. Negri, J. C. Perez-Diaz, F. Baquero, and J. Blazquez. 1995. New extended-spectrum TEM-type β-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. Antimicrob. Agents Chemother 39:458-461.
12. National Committee for Clinical Laboratory Standards. 1994 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2 National Committee for Clinical Laboratory Standards, Villanova, Pa.
13. Naumovski, L., J. P. Quinn, D. Miyashiro, M. Patel, K. Bush, S. B. Singer, D. Graves, T. Palzkill, and A. M. Arvin. 1992. Outbreak of ceftazidime resistance due to a novel extended-spectrum β-lactamase in isolates from cancer patients. Antimicrob. Agents Chemother. 36:1991-1996.
14. Palzkill, T., K. S. Thomson, C. C. Sanders, E. S. Moland, W. Huang, and T. W. Milligan. 1995. New variant of TEM-10 β-lactamase gene produced by a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 39: 1199-1200
15. Quinn, J. P., D. Mijashiro, D. Sahm, R. Flamm, and K. Bush. 1989. Novel plasmid-mediated β-lactamase (TEM-10) conferring selective resistance to ceftazidime and azrreonam in clinical isolates of Klebstella pneumaniae. Antimicrob. Agents Chemother. 33:1451-1456.
16. Rasmussen, B. A., P. A. Bradford, J. P. Quinn, J. Wiener, R. A. Weinstein, and K. Bush. 1993. Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 β-lactamases encoded by different nucleotide sequences. Antimicrob. Agents Chemother. 37:1989-1992.
17. Rice, L. B., S. H. Willey, G. A. Papanicolaou, A. A. Medeiros, G. M. Eliopoulos, R. C. Moellering, Jr., and G. A. Jacoby. 1990. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob. Agents Chemother. 34:2193-2199
18. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, vol. 1. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
19. Sutcliffe, J. G. 1978. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad Sci USA 75:3737-3741.
20. Sykes, R. B., D. P. Bonner, K. Bush, and N. H. Georgopapadakou. 1982. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrob. Agents Chemother. 21:85-92.
21. Urban, C., K. S. Meyer, N. Mariano, J. J. Rahal, R. Flamm, C. A. Rasmussen, and K. Bush. 1994. Identification of TEM-26 β-lactamase responsible for a major outbreak of ceftazidime-resistant Klebstella pneumoniae. Anti-microb. Agents Chemother. 38:392-395
22. Wiener, J., J. Quinn, C. Nathan, P. A. Bradford, K. Bush, R. Goering, and R. A. Weinstein. 1994. Molecular epidemiology of plasmid-mediated ceftazidime resistance (CAZ-R) in E. coli and Klebsiella pneumoniae in community nursing homes (NHs), abstr. C44, p. 87. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology, Washington, D.C.